Upsized Nasdaq IPO Yields Calliditas €80M to Commercialize Kidney Drug
Swedish company Calliditas Therapeutics has raised an €80M IPO on the Nasdaq Global Select Market…
Keep up to date with biotechnology regulations with the latest news on the industry’s most relevant political debates.
Swedish company Calliditas Therapeutics has raised an €80M IPO on the Nasdaq Global Select Market…
Update (04/06/2020): After upholding four of Kymab's patents addressing the production of antibody drugs earlier…
The Dutch biotech argenx has cashed in on recent positive phase III results by launching…
Following 2018’s bumper harvest for equity funding in European biotech, 2019 proved even more lucrative,…
The funding will go towards eight research projects that have been selected out of 144…
Despite the country being hard hit with Covid-19, Italian pharma seems to be getting back…
The European Commission and global donors have pledged €7.4 billion to a fund aimed at…
Covid-19 has been dominating the news for weeks on end, but what impact is the…
Update (30/04/2020): The French VC firm Kurma Partners has completed the final closing of its…
The French VC firm Sofinnova Partners has invested €20M in three Italian biotech companies via…
For a few decades, the worlds of biotech and digital technology have been on separate…
Healthcare investor Life Sciences Partners has closed the largest ever European venture capital fund dedicated…